MRSN logo

Mersana Therapeutics, Inc. (MRSN)

Profile

Full Name

Mersana Therapeutics, Inc.

Ticker

NASDAQ: MRSN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 28, 2017

Indexes

Not included

Website

https://www.mersana.com

Employees

102

Key Details

Price

$27.77(1.11%)

Market Cap

$138.47M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$40.50M(9.88% YoY)

Annual EPS

-$14.12(-854.76% YoY)

PE Ratio

-

Next earnings date

Mar 3, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $27.77
    MRSN price is $27.77

    30-Day Relative Volume

    0.28
    MRSN 30-day relative volume is 0.28

    Price Performance

    Price Most Recent Change

    +1.11%
    MRSN price was up +1.11% on Dec 5, 2025

    Price YTD Change

    -22.31%
    MRSN price is down -22.31% since January 1st

    Price 1-Year Change

    -52.11%
    MRSN price is down -52.11% year-on-year

    Price 3-Year Change

    -84.24%
    MRSN price is down -84.24% over the past 3 years

    Price Range

    Price All-Time High

    $727.25
    MRSN price is currently -96.18% below its historical high of $727.25

    Price 3-Year Low

    $5.21
    MRSN price is currently +433.11% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $138.47M
    MRSN market cap is $138.47 million

    Market Cap 3-Year Change

    -80.32%
    MRSN market cap is down -80.32% over the past 3 years

    Market Cap All-Time High

    $1.89B
    MRSN market cap is currently -92.67% below its historical high of $1.89 billion

    Market Cap Sector Percentile

    44.74%
    MRSN market cap is higher than 44.74% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.89%
    MRSN shares outstanding is up +0.89% year-on-year

    Shares Outstanding 3-Year Change

    +24.91%
    MRSN shares outstanding is up +24.91% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.84
    MRSN beta is 0.84

    200-day SMA

    $10.37
    MRSN price is currently +167.90% above its 200-day simple moving average

    50-day SMA

    $15.01
    MRSN price is currently +85.00% above its 50-day simple moving average

    14-Day RSI

    83.58
    MRSN 14-day relative strength index is 83.58

    Volume

    0.28
    MRSN 30-day relative volume is 0.28

    ATR

    $1.03
    MRSN average true range is $1.03

    10-day Historical Volatility

    12.55%
    MRSN 10-day historical volatility is 12.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $40.50M
    MRSN annual revenue is $40.50 million

    Revenue Analysts Estimate

    $23.07M
    MRSN annual revenue is currently +75.51% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +9.88%
    MRSN annual revenue is up +9.88% year-on-year

    Revenue Sector Percentile

    59.8%
    MRSN annual revenue is higher than 59.8% of companies in Healthcare sector

    EPS

    EPS

    -$14.12
    MRSN annual earnings per share is -$14.12

    EPS Analysts Estimate

    -$1.86
    MRSN annual earnings per share is currently -658.94% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -854.76%
    MRSN annual earnings per share is down -854.76% year-on-year

    EPS Sector Percentile

    12.35%
    MRSN annual earnings per share is higher than 12.35% of companies in Healthcare sector

    Profit

    Gross Profit

    $38.87M
    MRSN annual gross profit is $38.87 million

    Gross Margin

    95.98%
    MRSN annual gross profit margin is 95.98%

    Operating Profit

    -$73.34M
    MRSN annual operating income is -$73.34 million

    Operating Margin

    -181.09%
    MRSN annual operating profit margin is -181.09%

    Net Income

    -$69.19M
    MRSN annual net profit is -$69.19 million

    Net Margin

    -170.86%
    MRSN annual net profit margin is -170.86%

    Expenses

    Total Expenses

    $113.83M
    MRSN annual total expenses is $113.83 million

    Operating Expenses

    $113.83M
    MRSN annual total operating expenses is $113.83 million

    Cost Of Goods Sold

    $1.63M
    MRSN annual cost of goods sold is $1.63 million

    Selling, General & Administrative Expenses

    $40.81M
    MRSN annual SG&A is $40.81 million

    Depreciation & Amortization

    $1.63M
    MRSN annual D&A is $1.63 million

    Interest Expense

    $0.00
    MRSN annual interest expense is $0.00

    Income Tax

    $418.00K
    MRSN annual income tax is $418.00 thousand

    EBIT & EBITDA

    EBIT

    -$64.90M
    MRSN annual earnings before interest & taxes is -$64.90 million

    EBITDA

    -$63.27M
    MRSN annual EBITDA is -$63.27 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $144.66M
    MRSN annual total assets is $144.66 million

    Non Current Assets

    $7.76M
    MRSN annual long term assets is $7.76 million

    Current Assets

    $136.90M
    MRSN annual total current assets is $136.90 million

    Cash and Cash Equivalents

    $107.75M
    MRSN annual cash & cash equivalents is $107.75 million

    Accounts Receivable

    -
    MRSN annual accounts receivable value is unknown

    Inventory

    $0.00
    MRSN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $154.17M
    MRSN annual total liabilities is $154.17 million

    Long Term Liabilities

    $91.71M
    MRSN annual total long term liabilities is $91.71 million

    Current Liabilities

    $62.46M
    MRSN annual current liabilities is $62.46 million

    Accounts Payable

    $4.33M
    MRSN annual accounts payable is $4.33 million

    Debt

    Total Debt

    $28.65M
    MRSN annual total debt is $28.65 million

    Total Debt 1-Year Change

    -15.31%
    MRSN annual total debt is down -15.31% year-on-year

    Long Term Debt

    $12.25M
    MRSN annual long term debt is $12.25 million

    Short Term Debt

    $16.40M
    MRSN annual short term debt is $16.40 million

    Equity & Capital

    Shareholders Equity

    -$9.51M
    MRSN annual stockholders equity is -$9.51 million

    Book Value

    -$9.51M
    MRSN annual book value is -$9.51 million

    Retained Earnings

    -$895.55M
    MRSN annual retained earnings is -$895.55 million

    Working Capital

    $74.45M
    MRSN annual working capital is $74.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$82.34M
    MRSN annual cash from operations is -$82.34 million

    Cash From Operations 1-Year Change

    +51.24%
    MRSN annual cash from operations is up +51.24% year-on-year

    Cash From Investing

    $11.44M
    MRSN annual cash from investing is $11.44 million

    Cash From Investing 1-Year Change

    -90.46%
    MRSN annual cash from investing is down -90.46% year-on-year

    Cash From Financing

    $4.09M
    MRSN annual cash from financing is $4.09 million

    Cash From Financing 1-Year Change

    -95.68%
    MRSN annual cash from financing is down -95.68% year-on-year

    CAPEX

    CAPEX

    $132.00K
    MRSN annual capital expenditures is $132.00 thousand

    CAPEX 1-Year Change

    -93.91%
    MRSN annual capital expenditures is down -93.91% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$82.47M
    MRSN annual free cash flow is -$82.47 million

    Free Cash Flow 1-Year Change

    +51.78%
    MRSN annual free cash flow is up +51.78% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    95.98%
    MRSN annual gross profit margin is 95.98%

    Operating Margin

    -181.09%
    MRSN annual operating profit margin is -181.09%

    Net Margin

    -170.86%
    MRSN annual net profit margin is -170.86%

    ROA & ROE

    ROA

    -37.33%
    MRSN annual return on assets is -37.33%

    ROE

    -505.14%
    MRSN annual return on equity is -505.14%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    MRSN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    MRSN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -2.33
    MRSN price to book ratio is -2.33

    PB Ratio Sector Percentile

    8.58%
    MRSN price to book ratio is higher than 8.58% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    4.17
    MRSN price to sales ratio is 4.17

    PS Ratio Sector Percentile

    51.03%
    MRSN price to sales ratio is higher than 51.03% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $83.89M
    MRSN enterprise value is $83.89 million

    Enterprise Value Sector Percentile

    42.27%
    MRSN enterprise value is higher than 42.27% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.27
    MRSN EV/EBITDA is -1.27

    EV/EBITDA Sector Percentile

    44.76%
    MRSN EV/EBITDA is higher than 44.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.19
    MRSN annual current ratio is 2.19

    Quick Ratio

    2.19
    MRSN annual quick ratio is 2.19

    Leverage

    Debt To Equity

    -2.47
    MRSN annual debt to equity ratio is -2.47

    Interest Coverage Ratio

    -
    MRSN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    MRSN piotroski f-score is 3

    Altman Z-Score

    -8.71
    MRSN altman z-score is -8.71

    Analyst ratings

    Recent major analysts updates

    Nov 14, 25 Guggenheim
    Neutral
    Nov 13, 25 Truist Securities
    Hold
    Nov 13, 25 BTIG
    Neutral
    Aug 14, 25 Truist Securities
    Buy
    Aug 14, 25 Guggenheim
    Buy
    May 16, 25 Truist Securities
    Buy
    May 16, 25 Guggenheim
    Buy
    Feb 6, 25 William Blair
    Outperform
    Aug 27, 24 Citigroup
    Buy
    Aug 14, 24 Baird
    Neutral

    Institutional Ownership

    Screeners with MRSN included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Stocks ready to break out
    Healthcare sector
    All stocks
    • What is the ticker symbol for Mersana Therapeutics, Inc.?
    • Does Mersana Therapeutics, Inc. pay dividends?
    • What sector is Mersana Therapeutics, Inc. in?
    • What industry is Mersana Therapeutics, Inc. in?
    • What country is Mersana Therapeutics, Inc. based in?
    • When did Mersana Therapeutics, Inc. go public?
    • Is Mersana Therapeutics, Inc. in the S&P 500?
    • Is Mersana Therapeutics, Inc. in the NASDAQ 100?
    • Is Mersana Therapeutics, Inc. in the Dow Jones?
    • When was Mersana Therapeutics, Inc.'s last earnings report?
    • When does Mersana Therapeutics, Inc. report earnings?

    What is the ticker symbol for Mersana Therapeutics, Inc.?

    The ticker symbol for Mersana Therapeutics, Inc. is NASDAQ:MRSN

    Does Mersana Therapeutics, Inc. pay dividends?

    No, Mersana Therapeutics, Inc. does not pay dividends

    What sector is Mersana Therapeutics, Inc. in?

    Mersana Therapeutics, Inc. is in the Healthcare sector

    What industry is Mersana Therapeutics, Inc. in?

    Mersana Therapeutics, Inc. is in the Biotechnology industry

    What country is Mersana Therapeutics, Inc. based in?

    Mersana Therapeutics, Inc. is headquartered in United States

    When did Mersana Therapeutics, Inc. go public?

    Mersana Therapeutics, Inc.'s initial public offering (IPO) was on June 28, 2017

    Is Mersana Therapeutics, Inc. in the S&P 500?

    No, Mersana Therapeutics, Inc. is not included in the S&P 500 index

    Is Mersana Therapeutics, Inc. in the NASDAQ 100?

    No, Mersana Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Mersana Therapeutics, Inc. in the Dow Jones?

    No, Mersana Therapeutics, Inc. is not included in the Dow Jones index

    When was Mersana Therapeutics, Inc.'s last earnings report?

    Mersana Therapeutics, Inc.'s most recent earnings report was on November 14, 2025

    When does Mersana Therapeutics, Inc. report earnings?

    The next expected earnings date for Mersana Therapeutics, Inc. is March 3, 2026
    On this page